SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 34 filers reported holding SCPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $239 | +256.7% | 23,528 | +214.0% | 0.00% | – |
| Q1 2023 | $67 | -65.1% | 7,492 | -72.1% | 0.00% | – |
| Q4 2022 | $192 | -99.9% | 26,849 | +26.5% | 0.00% | – |
| Q3 2022 | $138,000 | -52.1% | 21,219 | -64.6% | 0.00% | – |
| Q2 2022 | $288,000 | +119.8% | 59,915 | +158.7% | 0.00% | – |
| Q1 2022 | $131,000 | +6450.0% | 23,156 | +4196.1% | 0.00% | – |
| Q4 2021 | $2,000 | – | 539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |